FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091158341> ?p ?o ?g. }

• W3091158341 endingPage "4552" @default.
• W3091158341 startingPage "4552" @default.
• W3091158341 abstract "The impact of excitotoxicity mediated by N-methyl-D-aspartate (NMDA) receptor overactivation and voltage gated calcium channel (VGCC) depolarization is prominent among the postulated processes involved in the development of neurodegenerative disorders. NGP1-01, a polycyclic amine, has been shown to be neuroprotective through modulation of the NMDA receptor and VGCC, and attenuation of MPP+-induced neurotoxicity. Recently, we reported on the calcium modulating effects of tricycloundecene derivatives, structurally similar to NGP1-01, on the NMDA receptor and VGCC of synaptoneurosomes. In the present study, we investigated novel 4-oxatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione derivatives for their cytotoxicity, neuroprotective effects via attenuation of MPP+-induced neurotoxicity and calcium influx inhibition abilities through the NMDA receptor and VGCC using neuroblastoma SH-SY5Y cells. All compounds, in general, showed low or no toxicity against neuroblastoma cells at 10–50 µM concentrations. At 10 µM, all compounds significantly attenuated MPP+-induced neurotoxicity as evident by the enhancement in cell viability between 23.05 ± 3.45% to 53.56 ± 9.29%. In comparison to known active compounds, the derivatives demonstrated mono or dual calcium modulating effect on the NMDA receptor and/or VGCC. Molecular docking studies using the NMDA receptor protein structure indicated that the compounds are able to bind in a comparable manner to the crystallographic pose of MK-801 inside the NMDA ion channel. The biological characteristics, together with results from in silico studies, suggest that these compounds could act as neuroprotective agents for the purpose of halting or slowing down the degenerative processes in neuronal cells." @default.
• W3091158341 created "2020-10-08" @default.
• W3091158341 creator A5001457240 @default.
• W3091158341 creator A5009009533 @default.
• W3091158341 creator A5032452076 @default.
• W3091158341 creator A5067539766 @default.
• W3091158341 creator A5081074027 @default.
• W3091158341 date "2020-10-05" @default.
• W3091158341 modified "2023-10-14" @default.
• W3091158341 title "4-Oxatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione Derivatives as NMDA Receptor- and VGCC Blockers with Neuroprotective Potential" @default.
• W3091158341 cites W1578829945 @default.
• W3091158341 cites W1967480902 @default.
• W3091158341 cites W1971324155 @default.
• W3091158341 cites W1982505129 @default.
• W3091158341 cites W1986668609 @default.
• W3091158341 cites W1995056605 @default.
• W3091158341 cites W2017321195 @default.
• W3091158341 cites W2020803251 @default.
• W3091158341 cites W2020889790 @default.
• W3091158341 cites W2024205788 @default.
• W3091158341 cites W2029308087 @default.
• W3091158341 cites W2030152904 @default.
• W3091158341 cites W2031358210 @default.
• W3091158341 cites W2034501523 @default.
• W3091158341 cites W2035037358 @default.
• W3091158341 cites W2037337146 @default.
• W3091158341 cites W2044502433 @default.
• W3091158341 cites W2054859530 @default.
• W3091158341 cites W2070996802 @default.
• W3091158341 cites W2072760452 @default.
• W3091158341 cites W2083004303 @default.
• W3091158341 cites W2085663480 @default.
• W3091158341 cites W2087035739 @default.
• W3091158341 cites W2089642515 @default.
• W3091158341 cites W2092311577 @default.
• W3091158341 cites W2128752618 @default.
• W3091158341 cites W2146704884 @default.
• W3091158341 cites W2396930286 @default.
• W3091158341 cites W2593436234 @default.
• W3091158341 cites W2748254337 @default.
• W3091158341 cites W2790030771 @default.
• W3091158341 cites W2804035339 @default.
• W3091158341 cites W2904256040 @default.
• W3091158341 cites W2914743334 @default.
• W3091158341 cites W2920924601 @default.
• W3091158341 cites W2949117276 @default.
• W3091158341 cites W2952725710 @default.
• W3091158341 cites W2974147246 @default.
• W3091158341 cites W2988745171 @default.
• W3091158341 cites W3004777349 @default.
• W3091158341 cites W3048821490 @default.
• W3091158341 cites W3092213440 @default.
• W3091158341 doi "https://doi.org/10.3390/molecules25194552" @default.
• W3091158341 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7582567" @default.
• W3091158341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33027964" @default.
• W3091158341 hasPublicationYear "2020" @default.
• W3091158341 type Work @default.
• W3091158341 sameAs 3091158341 @default.
• W3091158341 citedByCount "0" @default.
• W3091158341 crossrefType "journal-article" @default.
• W3091158341 hasAuthorship W3091158341A5001457240 @default.
• W3091158341 hasAuthorship W3091158341A5009009533 @default.
• W3091158341 hasAuthorship W3091158341A5032452076 @default.
• W3091158341 hasAuthorship W3091158341A5067539766 @default.
• W3091158341 hasAuthorship W3091158341A5081074027 @default.
• W3091158341 hasBestOaLocation W30911583411 @default.
• W3091158341 hasConcept C12554922 @default.
• W3091158341 hasConcept C170493617 @default.
• W3091158341 hasConcept C178790620 @default.
• W3091158341 hasConcept C185592680 @default.
• W3091158341 hasConcept C18699975 @default.
• W3091158341 hasConcept C25498285 @default.
• W3091158341 hasConcept C2779491297 @default.
• W3091158341 hasConcept C2781012912 @default.
• W3091158341 hasConcept C29730261 @default.
• W3091158341 hasConcept C519063684 @default.
• W3091158341 hasConcept C55493867 @default.
• W3091158341 hasConcept C61174792 @default.
• W3091158341 hasConcept C67018056 @default.
• W3091158341 hasConcept C86803240 @default.
• W3091158341 hasConcept C98274493 @default.
• W3091158341 hasConceptScore W3091158341C12554922 @default.
• W3091158341 hasConceptScore W3091158341C170493617 @default.
• W3091158341 hasConceptScore W3091158341C178790620 @default.
• W3091158341 hasConceptScore W3091158341C185592680 @default.
• W3091158341 hasConceptScore W3091158341C18699975 @default.
• W3091158341 hasConceptScore W3091158341C25498285 @default.
• W3091158341 hasConceptScore W3091158341C2779491297 @default.
• W3091158341 hasConceptScore W3091158341C2781012912 @default.
• W3091158341 hasConceptScore W3091158341C29730261 @default.
• W3091158341 hasConceptScore W3091158341C519063684 @default.
• W3091158341 hasConceptScore W3091158341C55493867 @default.
• W3091158341 hasConceptScore W3091158341C61174792 @default.
• W3091158341 hasConceptScore W3091158341C67018056 @default.
• W3091158341 hasConceptScore W3091158341C86803240 @default.
• W3091158341 hasConceptScore W3091158341C98274493 @default.
• W3091158341 hasIssue "19" @default.
• W3091158341 hasLocation W30911583411 @default.

• next